Form 8-K - Current report:
SEC Accession No. 0001104659-21-061038
Filing Date
2021-05-04
Accepted
2021-05-04 16:43:24
Documents
14
Period of Report
2021-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2115171d1_8k.htm   iXBRL 8-K 28033
2 EXHIBIT 99.1 tm2115171d1_ex99-1.htm EX-99.1 169658
6 GRAPHIC image_001.jpg GRAPHIC 3606
  Complete submission text file 0001104659-21-061038.txt   397807

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cyrx-20210504.xsd EX-101.SCH 3187
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cyrx-20210504_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cyrx-20210504_pre.xml EX-101.PRE 22711
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2115171d1_8k_htm.xml XML 3591
Mailing Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027
Business Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027 (949) 232-1900
Cryoport, Inc. (Filer) CIK: 0001124524 (see all company filings)

EIN.: 880313393 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34632 | Film No.: 21889259
SIC: 2834 Pharmaceutical Preparations